AI Analysis AI Analysis of INO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add INO to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Inovio Pharmaceuticals stock upgraded to Sell Candidate
(Updated on Jun 12, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 28, 2026 Loss -15.38%

No changes to the price of Inovio Pharmaceuticals stock on the last trading day (Friday, 12th Jun 2026). During the last trading day the stock fluctuated 4.09% from a day low at $1.10 to a day high of $1.15. The price has fallen in 5 of the last 10 days and is down by -16.03% for this period.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -22.71% during the next 3 months and, with a 90% probability hold a price between $0.589 and $1.01 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

INO Signals & Forecast

There are few to no technical positive signals at the moment. The Inovio Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.10 and $1.22. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, May 08, 2026, and so far it has fallen -24.66%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".

Support, Risk & Stop-loss for Inovio Pharmaceuticals stock

Inovio Pharmaceuticals finds support from accumulated volume at $1.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0450 between high and low, or 4.09%. For the last week the stock has had daily average volatility of 4.56%.

Inovio Pharmaceuticals is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INO) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Inovio Pharmaceuticals to open at $1.12, and during the day (based on 14 day Average True Range), to move between $1.06 and $1.14, which gives a possible trading interval of +/-$0.0862 (+/-8.16%) up or down from last closing price. If Inovio Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 8.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.09 (0.91%) than the resistance at $1.13 (2.73%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Inovio Pharmaceuticals stock A Buy?

Inovio Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.820 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $1.12 ( 1.36%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

INO Performance

Trading levels for INO

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.16 5.45%
R2 1.14 3.89%
R1 1.13 2.93%
Price 1.10
S1 1.10 -0.199%
S2 1.09 -1.16%
S3 1.07 -2.73%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.22 10.91%
R2 1.19 8.18%
R1 1.13 2.73%
Price 1.10
S1 1.09 -0.91%
S2 1.07 -2.73%
S3 1.05 -4.55%

INO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 21, 2017 Sep 28, 2017 Oct 16, 2017 $0.0690 0.0926%
2 Aug 22, 2017 Aug 29, 2017 Sep 15, 2017 $0.0690 0.0963%
3 Jul 25, 2017 Jul 27, 2017 Aug 15, 2017 $0.0690 0.102%
4 Jun 23, 2017 Jun 28, 2017 Jul 17, 2017 $0.0690 0.0740%

FAQ

What is the symbol for Inovio Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Inovio Pharmaceuticals is INO and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Inovio Pharmaceuticals Stock?
Inovio Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Inovio Pharmaceuticals Stock?
Inovio Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Inovio Pharmaceuticals Stock.

What's the current price of Inovio Pharmaceuticals Stock?
As of the end of day on the Jun 12, 2026, the price of an Inovio Pharmaceuticals (INO) share was $1.10.

What is the 52-week high and low for Inovio Pharmaceuticals Stock?
The 52-week high for Inovio Pharmaceuticals Stock is $2.98 and the 52-week low is $1.03.

What is the market capitalization of Inovio Pharmaceuticals Stock?
As of the Jun 12, 2026, the market capitalization of Inovio Pharmaceuticals is 58.949M.

When is the next earnings date for Inovio Pharmaceuticals?
The upcoming earnings date for Inovio Pharmaceuticals is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT INOVIO PHARMACEUTICALS
Inovio Pharmaceuticals
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery o...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE